Keywords: Costeffective generics, Chronic treatment, USA, CVS Caremark, Harvard

Generic drugs changing the economics of treating chronically ill patients, US study finds

Article | 07 July 2011

As the USA seeks to expand health care coverage to more citizens without adding burdensome costs, researchers from Harvard University, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in